Showing 1 - 9 results of 9 for search 'A. V. Elonakov', query time: 0.03s Refine Results
  1. 1
    Opyt mnogoletnego primeneniya sandimmuna neorala u patsientov s bolezn'yu Bekhcheta (obzor literatury i sobstvennye nablyudeniya)

    Opyt mnogoletnego primeneniya sandimmuna neorala u patsientov s bolezn'yu Bekhcheta (obzor literatury i sobstvennye nablyudeniya) by Z S Alekberova, A V Elonakov, N A Ermakova

    Published 2008-04-01
    Get full text
    Article
  2. 2
    Neurological signs of Behcet’s disease

    Neurological signs of Behcet’s disease by Z S Alekberova, L A Kalashnikova, R G Goloeva, A. V. Elonakov

    Published 2007-06-01
    Get full text
    Article
  3. 3
    KONSUPREN IN THETHERAPY OF RHEUMATIC DISEASES

    KONSUPREN IN THETHERAPY OF RHEUMATIC DISEASES by Z S Alekberova, N. S.V. Shekshina, A. V. Elonakov, V A Nassonova, Z S Alekberova

    Published 2001-04-01
    Get full text
    Article
  4. 4
    Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis

    Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis by Tatyana Valentinovna Mezenova, V P Tyurin, S Yu Davidyan, N A Kiryukhina, A V Elonakov

    Published 2012-04-01
    Get full text
    Article
  5. 5
    Behcet's disease and joint affection

    Behcet's disease and joint affection by Z S Alekberova, A V Elonakov, R G Goloeva, A V Smirnov, I A Guseva, E L Nasonov

    Published 2008-05-01
    Get full text
    Article
  6. 6
    THE TIME COURSE OF CHANGES IN B LYMPHOCYTE SUBPOPULATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS DURING THERAPY WITH BIOLOGICAL AGENTS

    THE TIME COURSE OF CHANGES IN B LYMPHOCYTE SUBPOPULATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS DURING THERAPY WITH BIOLOGICAL AGENTS by A. A. Mesnyankina, S. K. Solovyev, E. N. Aleksandrova, A. P. Aleksankin, E. V. Suponitskaya, A. V. Elonakov, E. A. Aseeva, E. L. Nasonov

    Published 2017-07-01
    Get full text
    Article
  7. 7
    Efficiency of tocilizumab therapy for an exacerbation of systemic lupus erythematosus: A case report and a review of literature

    Efficiency of tocilizumab therapy for an exacerbation of systemic lupus erythematosus: A case report and a review of literature by S. K. Solovyev, A. A. Mesnyankina, D. E. Karateev, E. L. Luchikhina, Ya. A. Sigidin, E. A. Aseeva, A. V. Elonakov, E. L. Nasonov

    Published 2017-09-01
    Get full text
    Article
  8. 8
    CLINICAL CHARACTERISTICS OF ANKYLOSING SPONDYLITIS IN REAL PRACTICE IN RUSSIA: RESULTS OF THE CROSS-SECTIONAL NON-INTERVENTIONAL TRIAL EPICA2

    CLINICAL CHARACTERISTICS OF ANKYLOSING SPONDYLITIS IN REAL PRACTICE IN RUSSIA: RESULTS OF THE CROSS-SECTIONAL NON-INTERVENTIONAL TRIAL EPICA2 by Sh. F. Erdes, T. V. Dubinina, D. E. Abdulganieva, I. B. Vinogradova, L. P. Evstigneeva, A. V. Elonakov, E. N. Otteva, T. A. Raskina, T. S. Salnikova, R. R. Samigullina, V. N. Sorotskaya, L. M. Shkil

    Published 2016-09-01
    Get full text
    Article
  9. 9
    The efficiency and safety of tocilizumab in rheumatoid arthritis(intermediate results of a Russian multicenter study)

    The efficiency and safety of tocilizumab in rheumatoid arthritis(intermediate results of a Russian multicenter study) by E L Nasonov, Elena Yuryevna Panasyuk, S G Buldakov, A B Pavlova, L A Knyazeva, R G Kamalova, I B Vinogradova, E A Shikina, T A Raskina, A A Dmitriyeva, R S Saikovsky, A V Elonakov, V N Amirdzhanova, E N Aleksandrova

    Published 2010-04-01
    Get full text
    Article

Search Tools: